Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role.
intrahepatic cholangiocarcinoma
liver cirrhosis
non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
outcome
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
29 Oct 2020
29 Oct 2020
Historique:
received:
07
09
2020
revised:
21
10
2020
accepted:
27
10
2020
entrez:
3
11
2020
pubmed:
4
11
2020
medline:
4
11
2020
Statut:
epublish
Résumé
Non-alcoholic fatty liver disease (NAFLD) and its most aggressive form, non-alcoholic steatohepatitis (NASH), are causing a rise in the prevalence of hepatocellular carcinoma. Data about NAFLD/NASH and intrahepatic cholangiocarcinoma (iCCA) are few and contradictory, coming from population registries that do not correctly distinguish between NAFLD and NASH. We evaluated the prevalence of NAFLD and NASH in peritumoral tissue of resected iCCA (
Identifiants
pubmed: 33138044
pii: cancers12113182
doi: 10.3390/cancers12113182
pmc: PMC7692633
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cell. 2018 Oct 18;175(3):679-694.e22
pubmed: 30340040
J Hepatol. 2014 Jul;61(1):75-81
pubmed: 24607626
PLoS One. 2013 Jul 22;8(7):e69981
pubmed: 23894567
Epidemiology. 2016 May;27(3):368-77
pubmed: 26841057
Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):160-174
pubmed: 30518830
Aliment Pharmacol Ther. 2018 Oct;48(7):696-703
pubmed: 30136293
Cancer Epidemiol. 2016 Feb;40:179-87
pubmed: 26773278
Ann Intern Med. 2017 Aug 15;167(4):268-274
pubmed: 28693043
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Hepatology. 2011 Jul;54(1):344-53
pubmed: 21520200
Hepatology. 2016 Mar;63(3):827-38
pubmed: 26599351
Dig Liver Dis. 2019 Aug;51(8):1067-1073
pubmed: 31208929
Clin Gastroenterol Hepatol. 2007 Oct;5(10):1221-8
pubmed: 17689296
Liver Int. 2011 Mar;31(3):377-85
pubmed: 21108736
J Hepatol. 2014 Jun;60(6):1268-89
pubmed: 24681130
Carcinogenesis. 2017 Mar 1;38(3):231-240
pubmed: 28426878
Hepatology. 2019 Apr;69(4):1803-1815
pubmed: 30251463
World J Surg. 2019 Aug;43(8):2048-2060
pubmed: 30949764
World J Gastroenterol. 2008 Jan 28;14(4):632-5
pubmed: 18203300
Aliment Pharmacol Ther. 2017 Nov;46(9):856-863
pubmed: 28857208
Int J Mol Sci. 2017 May 25;18(6):
pubmed: 28587063
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Hepatology. 2016 Sep;64(3):785-96
pubmed: 26940227
J Hepatol. 2016 Jun;64(6):1388-402
pubmed: 27062661
J Surg Oncol. 2016 Jun;113(7):779-83
pubmed: 26996383
Hepatology. 2014 Aug;60(2):565-75
pubmed: 24753132
Hepatology. 2019 Jan;69(1):107-120
pubmed: 29665135
BMC Gastroenterol. 2012 Mar 01;12:20
pubmed: 22380754
BMC Gastroenterol. 2017 Dec 8;17(1):149
pubmed: 29216833
J Gastrointest Surg. 2011 Apr;15(4):608-13
pubmed: 21246412
Eur J Gastroenterol Hepatol. 2018 May;30(5):552-556
pubmed: 29280922
J Gastrointest Surg. 2013 Apr;17(4):748-55
pubmed: 23355033
J Gastrointest Surg. 2014 Mar;18(3):562-72
pubmed: 24395070